Ayala Pharmaceuticals Inc (ADXS)

[cab033]

I absolutely agree. But this does not need Nuclear Level Warfare news to drop 20%+. It can do that on its own with just a business outlook PR. The R/S and a secondary will become more discussed topics on this board in the near future I bet.

Just some things to consider: delisting regulations, institutional portfolio re-evaluations (we are nearing Q end, this could remain sub $5 by then), $ needs assuming a "deal" is not struck. Lots to think about I/m/o

If secondary would get the shorts to go away I think they should consider it. But if they are waiting and pushing for zero then this could get ugly.